Impact Factor 2021: 3.041 (@Clarivate Analytics)
5-Year Impact Factor: 2.776 (@Clarivate Analytics)
Impact Factor Rank: 10/24, Q2 (Tropical Medicine)
  • Users Online: 928
  • Print this page
  • Email this page

    Article Cited by others

LETTER TO EDITOR

Dose prediction of lopinavir/ritonavir for 2019-novel coronavirus (2019-nCoV) infection based on mathematic modeling

Yasri Sora, Wiwanitkit Viroj

Year : 2020| Volume: 13| Issue : 3 | Page no: 137-138

   This article has been cited by
 
1 The impact of COVID-19 on the comorbidities: A review of recent updates for combating it
Jonaid Ahmad Malik, Sakeel Ahmed, Mrunal Shinde, Mohammed Hajjaj Saeid Al-Marmash, Saleh Alghamdi, Arshad Hussain, Sirajudheen Anwar
Saudi Journal of Biological Sciences. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 COVID-19 in HIV-infected individuals
Pathum Sookaromdee, Viroj Wiwanitkit
Revista da Associação Médica Brasileira. 2022; 68(2): 135
[Pubmed]  [Google Scholar] [DOI]
3 Dermatology practice in the times of the COVID-19 pandemic
Deepak Vashisht,Shekhar Neema,Ruby Venugopalan,Vikas Pathania,Sunmeet Sandhu,Biju Vasudevan
Indian Journal of Dermatology, Venereology and Leprology. 2021; 0: 1
[Pubmed]  [Google Scholar] [DOI]
4 Insights into the binding properties of calf thymus DNA with lopinavir from spectroscopic and computational studies
Song-Bo Kou,Kai-Li Zhou,Zhen-Yi Lin,Yan-Yue Lou,Jie-Hua Shi,Ying-Xin Liu
Journal of Molecular Liquids. 2021; : 115491
[Pubmed]  [Google Scholar] [DOI]
5 Evidence of Protective Effect of Hydroxychloroquine on COVID-19
Beuy Joob,Viroj Wiwanitkit
The Journal of Rheumatology. 2020; 47(10): 1587.1
[Pubmed]  [Google Scholar] [DOI]
6

COVID-19-Related Knowledge, Attitude and Practice Among Hospital and Community Pharmacists in Addis Ababa, Ethiopia

Zelalem Tilahun Tesfaye,Malede Berihun Yismaw,Zenebe Negash,Akeberegn Gorems Ayele
Integrated Pharmacy Research and Practice. 2020; Volume 9: 105
[Pubmed]  [Google Scholar] [DOI]
7 SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment
Beuy Joob,Viroj Wiwanitkit
Annals of the Rheumatic Diseases. 2020; 79(6): e61
[Pubmed]  [Google Scholar] [DOI]
8 SARS-CoV-2 and HIV
Beuy Joob,Viroj Wiwanitkit
Journal of Medical Virology. 2020;
[Pubmed]  [Google Scholar] [DOI]
9 Pharmacological treatments of COVID-19
Adeleh Sahebnasagh,Razieh Avan,Fatemeh Saghafi,Mojataba Mojtahedzadeh,Afsaneh Sadremomtaz,Omid Arasteh,Asal Tanzifi,Fatemeh Faramarzi,Reza Negarandeh,Mohammadreza Safdari,Masoud Khataminia,Hassan Rezai Ghaleno,Solomon Habtemariam,Amirhosein Khoshi
Pharmacological Reports. 2020;
[Pubmed]  [Google Scholar] [DOI]
10 Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review
Kawthar Mohamed,Niloufar Yazdanpanah,Amene Saghazadeh,Nima Rezaei
Bioorganic Chemistry. 2020; : 104490
[Pubmed]  [Google Scholar] [DOI]
11 COVID-19 and comorbidities: Deleterious impact on infected patients
Hasan Ejaz,Abdullah Alsrhani,Aizza Zafar,Humera Javed,Kashaf Junaid,Abualgasim E. Abdalla,Khalid O.A. Abosalif,Zeeshan Ahmed,Sonia Younas
Journal of Infection and Public Health. 2020;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article